Guidance for Industry and FDA: User Fees and Refunds for Premarket Approval Applications
A draft guidance has been issued for comment purposes only, see “Draft Guidance for Industry and FDA Staff: User Fees and Refunds for Premarket Approval Applications” issued March 13, 2009, which if issued as final, will replace the currently available guidance which was [...]


Loading...
